David Collier
Overview
Explore the profile of David Collier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
4512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
La Merrill M, Smith M, McHale C, Heindel J, Atlas E, Cave M, et al.
Nat Rev Endocrinol
. 2024 Nov;
PMID: 39613954
Metabolism-disrupting agents (MDAs) are chemical, infectious or physical agents that increase the risk of metabolic disorders. Examples include pharmaceuticals, such as antidepressants, and environmental agents, such as bisphenol A. Various...
2.
Claiborne A, Wisseman B, Kern K, Steen D, Jevtovic F, McDonald S, et al.
Eur J Obstet Gynecol Reprod Biol
. 2024 Jul;
300:190-195.
PMID: 39025039
Background: Preterm delivery typically increases health risk for neonates and is associated with longer infant hospital stay and financial burden. Prenatal exercise dose (frequency, intensity, type, time, volume) have been...
3.
Claiborne A, Wisseman B, Kern K, Steen D, Jevtovic F, McDonald S, et al.
Birth Defects Res
. 2024 Apr;
116(4):e2340.
PMID: 38659157
Background: Prenatal exercise improves birth outcomes, but research into exercise dose-response effects is limited. Methods: This study is a retrospective, secondary analysis of pooled data from three blinded, prospective, randomized...
4.
Jakicic J, Kohrt W, Houmard J, Miller M, Radom-Aizik S, Rasmussen B, et al.
J Appl Physiol (1985)
. 2024 Apr;
137(3):473-493.
PMID: 38634503
Physical activity, including structured exercise, is associated with favorable health-related chronic disease outcomes. Although there is evidence of various molecular pathways that affect these responses, a comprehensive molecular map of...
5.
Jin R, Kruppert S, Scholz F, Bardoulat I, Karzazi K, Morand F, et al.
Rheumatol Ther
. 2024 Mar;
11(3):523-537.
PMID: 38436916
Introduction: ABP 501 was an adalimumab (ADA) biosimilar approved for treating immune-mediated inflammatory diseases (IMIDs) including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). In this retrospective study,...
6.
Kotlarz N, McCord J, Collier D, Suzanne Lea C, Strynar M, Lindstrom A, et al.
Environ Health Perspect
. 2024 Feb;
132(2):29002.
PMID: 38358997
No abstract available.
7.
Dang A, Kiropoulos L, Anderluh M, Collier D, Fernandez-Aranda F, Karwautz A, et al.
J Eat Disord
. 2024 Jan;
12(1):5.
PMID: 38212857
Background: The current study examined whether risk factors for anorexia nervosa (AN) were related to different levels of severity based on (a) the DSM-5/body mass index (BMI) and (b) drive...
8.
Kotlarz N, Guillette T, Critchley C, Collier D, Suzanne Lea C, McCord J, et al.
J Expo Sci Environ Epidemiol
. 2024 Jan;
34(1):97-107.
PMID: 38195989
Background: A fluorochemical facility near Fayetteville, North Carolina, emitted per- and polyfluoroalkyl ether acids (PFEAs), a subgroup of per- and polyfluoroalkyl substances (PFAS), to air. Objective: Analyze PFAS in private...
9.
Cousins O, Schubert J, Chandra A, Veronese M, Valkimadi P, Creese B, et al.
J Neuroinflammation
. 2023 Nov;
20(1):272.
PMID: 37990275
Background: Microglia are increasingly understood to play an important role in the pathogenesis of Alzheimer's disease. The rs75932628 (p.R47H) TREM2 variant is a well-established risk factor for Alzheimer's disease. TREM2...
10.
Madurasinghe V, Knapp P, Eldridge S, Collier D, Treweek S, Rick J, et al.
BMC Med
. 2023 Nov;
21(1):425.
PMID: 37940944
Background: People need high-quality information to make decisions about research participation. Providing information in written format alone is conventional but may not be the most effective and acceptable approach. We...